A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
Clinical trial NCT04866160 · COMPLETED
Trial details
- NCT number
- NCT04866160
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-17
- Primary completion
- 2021-11-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.